Amy A Vaughan Ii, MD in Barboursville, WV - Medicare Dermatology

Amy A Vaughan Ii, MD is a medicare enrolled "Dermatology" physician in Barboursville, West Virginia. She went to Jc Edwards School Of Medicine, Marshall University and graduated in 1992 and has 32 years of diverse experience with area of expertise as Dermatology. She is a member of the group practice Amy A Vaughan Dermatology Pllc and her current practice location is 6007 Us Route 60 E, Suite 130, Barboursville, West Virginia. You can reach out to her office (for appointments etc.) via phone at (304) 733-3333.

Amy A Vaughan Ii is licensed to practice in West Virginia (license number 18579) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1073503223.

Contact Information

	Amy A Vaughan Ii, MD
	6007 Us Route 60 E, Suite 130, Barboursville, WV 25504-1042
	(304) 733-3333
	(304) 733-3666

Physician's Profile

Full Name	Amy A Vaughan Ii
Gender	Female
Speciality	Dermatology
Experience	32 Years
Location	6007 Us Route 60 E, Barboursville, West Virginia
Accepts Medicare Assignments	Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Amy A Vaughan Ii attended and graduated from Jc Edwards School Of Medicine, Marshall University in 1992

NPI Data:

NPI Number: 1073503223
Provider Enumeration Date: 10/27/2005
Last Update Date: 07/08/2007

Medicare PECOS Information:

PECOS PAC ID: 0446257125
Enrollment ID: I20061024000088

Medical Identifiers

Medical identifiers for Amy A Vaughan Ii such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1073503223	NPI	-	NPPES
0070108000	Medicaid	WV

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207N00000X	Dermatology	18579 (West Virginia)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Cabell Huntington Hospital Inc	Huntington, WV	Hospital
St Mary's Medical Center	Huntington, WV	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Amy A Vaughan Dermatology Pllc	5890792485	4

News Archive

Intratumoral morphological diversity of breast cancer not related to chromosome aberrations

Intratumor morphological heterogeneity (diversity) of breast cancer is not related to chromosome aberrations. This conclusion was made based on the study of one case with aggressive variant of breast cancer - invasive micropapillary carcinoma by researchers from Tomsk State University, Tomsk Cancer Research Institute, and Institute of Medical Genetics.

FDA designates Synageva's sebelipase alfa as Breakthrough Therapy for early onset LAL Deficiency

Synageva BioPharma Corp., a biopharmaceutical company developing therapeutic products for rare diseases, today announced that the U.S. Food and Drug Administration granted Breakthrough Therapy designation to sebelipase alfa for the treatment of early onset lysosomal acid lipase deficiency, also known as Wolman disease.

American Chemistry Council calls on FDA to update review of Bisphenol A

The American Chemistry Council (ACC) today sent a letter to FDA Commissioner Andrew von Eschenbach requesting FDA to update its review of the safety of bisphenol A in food contact applications.

Risks associated with opioid pain medications may outweigh surgery risks

Despite limited evidence of long-term success in using opioid pain medications for chronic low back pain, opioid prescribing has increased in recent years for back pain and other non-cancer pain indications.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Amy A Vaughan Ii allows following entities to bill medicare on her behalf.

Entity Name	Amy A Vaughan Dermatology Pllc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1154411908 PECOS PAC ID: 5890792485 Enrollment ID: O20061024000217

News Archive

Intratumoral morphological diversity of breast cancer not related to chromosome aberrations

FDA designates Synageva's sebelipase alfa as Breakthrough Therapy for early onset LAL Deficiency

American Chemistry Council calls on FDA to update review of Bisphenol A

The American Chemistry Council (ACC) today sent a letter to FDA Commissioner Andrew von Eschenbach requesting FDA to update its review of the safety of bisphenol A in food contact applications.

Risks associated with opioid pain medications may outweigh surgery risks

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Amy A Vaughan Ii is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Amy A Vaughan Ii, MD Po Box 937, 6007 Us Route 60 E Suite 130, Barboursville, WV 25504 Ph: (304) 733-3333	Amy A Vaughan Ii, MD 6007 Us Route 60 E, Suite 130, Barboursville, WV 25504-1042 Ph: (304) 733-3333

News Archive

Intratumoral morphological diversity of breast cancer not related to chromosome aberrations

FDA designates Synageva's sebelipase alfa as Breakthrough Therapy for early onset LAL Deficiency

American Chemistry Council calls on FDA to update review of Bisphenol A

The American Chemistry Council (ACC) today sent a letter to FDA Commissioner Andrew von Eschenbach requesting FDA to update its review of the safety of bisphenol A in food contact applications.

Amy A Vaughan Ii, MD - Medicare Dermatology in Barboursville, WV

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Intratumoral morphological diversity of breast cancer not related to chromosome aberrations

FDA designates Synageva's sebelipase alfa as Breakthrough Therapy for early onset LAL Deficiency

American Chemistry Council calls on FDA to update review of Bisphenol A

Risks associated with opioid pain medications may outweigh surgery risks

Medicare Reassignments

Intratumoral morphological diversity of breast cancer not related to chromosome aberrations

FDA designates Synageva's sebelipase alfa as Breakthrough Therapy for early onset LAL Deficiency

American Chemistry Council calls on FDA to update review of Bisphenol A

Risks associated with opioid pain medications may outweigh surgery risks

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Intratumoral morphological diversity of breast cancer not related to chromosome aberrations

FDA designates Synageva's sebelipase alfa as Breakthrough Therapy for early onset LAL Deficiency

American Chemistry Council calls on FDA to update review of Bisphenol A

Risks associated with opioid pain medications may outweigh surgery risks

Dermatology Doctors in Barboursville, WV